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Complementation analysis of the combined Condit/Dales collection of vaccinia virus temperature-sensitive mutants has been reported
(Lackner, C.A., D'Costa, S.M., Buck, C., Condit, R.C., 2003. Complementation analysis of the Dales collection of vaccinia virus temperature-
sensitive mutants. Virology 305, 240–259), however not all complementation groups have previously been assigned to single genes on the viral
genome. We have used marker rescue to map at least one representative of each complementation group to a unique viral gene. The final combined
collection contains 124 temperature-sensitive mutants affecting 38 viral genes, plus five double mutants.
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Poxviruses are unusual among viruses in that they carry out
their replication entirely in the cell cytoplasm using a double
stranded DNA molecule as a genome (reviewed in Moss,
2007). To accomplish this feat, poxviruses use a relatively large
genome (∼200 genes) to encode an entire complement of
enzymes required for both mRNA synthesis and DNA
replication, thus bypassing a strict requirement for nuclear
enzymes. The most notorious of poxviruses is variola, the
causative agent of smallpox. The laboratory prototype for the
study of poxviruses is vaccinia virus, the poxvirus that was
used as a live vaccine for eradication of smallpox. Despite the⁎ Corresponding author.
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doi:10.1016/j.virol.2008.01.027eradication of smallpox, interest in poxviruses persists because
of their unusual structure, replication cycle and assembly, their
utility as tools for understanding basic mechanisms of nucleic
acid metabolism, the profound insights they provide into viral
strategies to combat the host immune response, and the
potential for deliberate release of smallpox as a bioterrorist
weapon.
The study of poxvirus biology has benefited significantly
from both classical and reverse genetic analysis. Classical
genetic analysis has consisted primarily of brute force isolation,
mapping and characterization of temperature-sensitive mutants
of the virus (Condit and Niles, 1990). A burst of classical genetic
analysis in the late 1970s yielded four significant collections of
temperature-sensitive mutants of vaccinia virus from the Condit,
Dales, Drillien and Ensinger laboratories (Condit andMotyczka,
1981; Condit et al., 1983; Dales et al., 1978; Ensinger, 1982;
Drillien et al., 1982; Drillien and Spehner, 1983). In 1986,
several mutants from the Ensinger collection were pooled with
mutants from the Condit collection during studies on the highly
conserved 16-kb HindIII DNA fragment of the vaccinia genome
(Seto et al., 1987). More recently, the Condit and Dales collec-
tions were polished and pooled by performing complementation
Table 2
Mutants mapped in this paper
Mutant Prior status Gene a
Dts77 U17 A3L
Cts13 U3 A10L
Dts2 U4 A10L
Dts48 U13 A20R
Dts16 U6 A29L
Dts17 U6 A29L
Dts15 B1R B1R
Dts36 U10 D1R
Dts50 U10 D1R
Dts95 U21 D6R
Dts61 U15 D11L
Cts52 E(2-8)a E6R
Dts41 E(2-8)a E6R
Dts80 E(2-8)a E6R
Dts18 U7 E9L
Dts20 U8 E9L
Dts83 U20 E9L
Dts97 U8 E9L
Dts19 E11L E11L
Cts30 F(11-17) F13L
Cts48 F(11-17) F13L
Dts33 U9 G5.5R
Cts41 G(6-8) G7L
Dts78 U18 H4L
Dts57 U14 H5R
Dts4 U5 I7L
Dts8 U5 I7L
Dts35 U5 I7L
Dts93 U5 I7L
Cts57 U1 I8R
Cts37 U2 LM12, 32 dbl
Dts40 U11 J3R–J4R dbl
Dts47 U12 LM19, 21 dbl
Dts71 U16 LM23, 26 dbl
Dts82 U19 J6R, A36R dbl
a dbl = double mutant, the smallest fragments producing rescue are indicated.
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mutants in the two collections (Lackner et al., 2003). The
resulting collection contained 129 temperature-sensitive
mutants sorted into 53 complementation groups. To maximize
the utility of this combined collection, we have now conducted
marker rescue analysis on at least one member of each com-
plementation group, so that each complementation group is now
identified with a unique vaccinia gene. In the course of the
mapping analysis, we discovered that some of the previous
complementation results represented false positives so that some
mutants which were thought to comprise new complementation
groups in fact mapped to genes containing previously mapped
temperature-sensitive mutants. In addition, five mutants proved
to be double mutants. The final pooled collection contains 124
usable temperature-sensitive mutants which map to 38 vaccinia
genes. The analysis identifies temperature-sensitive mutants in
eight new genes, and adds new temperature-sensitive alleles to
many other genes of interest. The collection represents a
valuable toolbox for study of viral functions affecting gene
expression, DNA replication and virus structure and assembly.
Results and discussion
Mapping of mutants by marker rescue
Our prior complementation analysis of temperature-sensitive
mutant viruses from the Condit and Dales mutant collections
revealed numerous mutants whose map positions in the vaccinia
genomewere unknown or uncertain (Tables 1 and 2). Specifically,
the analysis revealed 21 complementation groups (U1–U21)
comprising 24 viruseswhosemap positionswere totally unknown
and six complementation groups [A(8-17), A(25-29), E(2-8)a, E
(2-8)b, F(11-17), G(6-8)] representing 14 viruses that had pre-
viously been only coarsely mapped to a multi-gene region of the
viral genome. Furthermore, we reported map positions of three
mutants comprising two complementation groups (genes A3L
and J1R) as unpublished data, and numerous unmapped mutants
were assigned to specific genes based solely on complementation
analysis. Since publication of this prior study, data have been
published from our laboratory and from other laboratories which
map to a unique gene mutants in four of the six partially mappedTable 1
Mutants mapped since Lackner et al., (2003)
Mutant Prior status Gene Reference
Cts8 A3L A3L Kato et al. (2004)
Cts26 A3L A3L Kato et al. (2004)
Cts40 A(8-17) A13L Unger and Traktman (2004)
Cts6 A(25-29) A28L Turner et al. (2007)
Cts9 A(25-29) A28L Turner et al. (2007)
Dts27 D4R D4R Stanitsa et al. (2006)
Dts12 D5R D5R Boyle et al. (2007)
Dts56 D5R D5R Boyle et al. (2007)
Cts19 E(2-8)b E8R Kato et al. (2007)
Dts23 E(2-8)b E8R Kato et al. (2007)
Dts25 E(2-8)b E8R Kato et al. (2007)
Cts11 G(6-8) G7L Mercer and Traktman (2005)
Cts45 J1R J1R Chiu et al. (2005)complementation groups [A(8-17), A(25-29), E(2-8)b, G(6-8)],
confirm the mapping of the two unpublished complementation
groups (A3L and J1R), and confirm the map position inferred
from complementation analysis of three mutants in two genes
(D4R and D5R) (Table 1). Our goal in this study was to map the
remaining unmapped or coarsely mapped mutants (Table 2).
At least one representative virus of each unmapped comple-
mentation group was mapped by marker rescue. Marker rescue
was done by infecting monolayers of BSC40 cells with an ap-
propriate dilution of mutant virus, transfecting with subgenomic
PCR fragments of wild type virus DNA, incubating the infected,
transfected cells at the non-permissive temperature for 4 days,
and staining with crystal violet to detect rescued wild type virus
plaques. Mapping was done in stages using three sets of pro-
gressively smaller DNA fragments. Initial mapping used a set of
13 overlapping PCR products (YE fragments) ranging in size
from 12 to 22 kb and representing virtually the entire vaccinia
genome (Fig. 1A) (Yao and Evans, 2003). Refined map po-
sitions were then obtained using an appropriate selection of
fragments from a set of 41 overlapping 5-kb fragments (LM
fragments) representing the entire vaccinia genome (Fig. 1A)
(Luttge and Moyer, 2005). Lastly mutants were mapped to
Fig. 1. Coarse marker rescue mapping of Cts13. A) A HindIII map of the vaccinia genome showing the positions of large sized (YE) PCR fragments and intermediate
sized (LM) PCR fragments. B) Marker rescue of Cts13. Dishes were infected with Cts13, transfected with pools of PCR fragments as indicated, incubated at 39.7 °C
for 4 days, and stained with crystal violet.
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fragments. In many cases mapping data was supplemented with
DNA sequence analysis of the mapped mutants (Supplementary
Table 1). Figs. 1–3 show the sequential steps performed to
determine the precise physical map position of Cts134, one
representative unmapped virus of the collection. Fig. 1B shows
amarker rescue donewith pools of YE fragments, demonstrating
thatCts13maps within the region defined by fragments YE7 and
YE8. Fig. 2 shows that Cts13 rescues with YE7 but not YE8.
YE7 encompasses fragments LM25 through LM29 (Fig. 2A).
Fig. 2B shows thatCts13 rescues exclusively with LM28. LM28
encompasses vaccinia genes A8R–A12L (Fig. 3A). Fig. 3B
shows that Cts13 maps to gene A10L, which encodes the major
virion protein 4a.
The sequential marker rescue protocol was used to map 23
unmapped or partially mapped complementation groups of the
combined Condit and Dales collections comprising 32 viruses,
and to confirm themap positions inferred from complementation
analysis for three additional mutants. For mapping mutants that
had been partially mapped previously, we used an abbreviated4 Mutants prefaced with a “C”, “D” or “E” are from the Condit, Dales or
Ensinger collections, respectively.scheme in which we determined, based on the published pre-
liminary mapping, which long PCR products or 5-kb products
could be used as positive controls in the marker rescue, and the
remaining physical mapping was done as described.
The mapping results can be broken down into four categories
(Table 2): 1) Five mutants representing five unmapped com-
plementation groups proved to be double mutants (Cts37 = U2,
Dts40 = U11, Dts47 = U12, Dts71 = U16, Dts82 = U19) and
were therefore excluded from further analysis. The criteria for
classifying these as double mutants are discussed below. 2) The
map positions of three mutants inferred from prior comple-
mentation analysis were confirmed (Cts41 = G7L, Dts15 =
B1R, Dts19 = E11L). 3) Surprisingly, 13 mutants comprising 9
unmapped complementation groups (U1, U15, U17, U18, U20,
U21, U5, U7, U8) mapped to genes containing previously
isolated temperature-sensitive mutations. Thus these mutants
represent false positives from the prior complementation
analysis, discussed further below. 4) 14 mutants comprising 6
unmapped and 2 coarsely mapped complementation groups
were mapped to genes in which classical temperature-sensitive
mutations have not been previously identified (genes A10L,
A20R, A29L, D1R, E6R, F13L, G5.5R, and H5R). (Engineered
temperature-sensitive mutants have previously been isolated in
Fig. 2. Refined marker rescue mapping of Cts13. A) A map of a portion of the vaccinia genome containing the HindIII D–A junction, showing the positions of YE7,
and the LM fragments contained within YE7. B) Marker rescue of Cts13. Dishes were infected with Cts13, transfected with pools of PCR fragments as indicated,
incubated at 39.7 °C for 4 days, and stained with crystal violet. LM all contains LM fragments 25–34, covering YE7 and YE8.
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1997; DeMasi and Traktman, 2000; Punjabi et al., 2001).)
Four of the double mutants (Dts82,Cts37,Dts47,Dts71) were
designated as such because each rescued with two non-over-
lappingDNA fragments.We interpret this tomean that each of the
rescuing fragments contains a temperature-sensitive allele that by
itself is insufficient to confer full temperature sensitivity on virus
replication, but in combination with the second allele prevents
virus growth at the non-permissive temperature. The remaining
double mutant, Dts40, presents a noteworthy curiosity. Fine
mapping ofDts40 revealed that the mutant could be rescued with
a PCR fragment containing both the J3R and the J4R genes,
however the mutant could not be rescued with fragments
representing the individual genes. We therefore sequenced the
J3R and J4R genes fromDts40 and found a single point mutation
in an 86 bp region of overlap between J3R and J4R resulting in a
substitution in both J3R (R323K) and J4R (E18K) (Fig. 4). The
sequence in this region of overlap is arranged such that we could
not easily segregate these mutations for further analysis. In
retrospect, it should theoretically have been possible to rescue the
Dts40 mutation with the individual J3R or J4R gene fragments,
however the mutation is located only 35 nucleotides from the C
terminus of J3R and 52 nucleotides from the N terminus of J4R.
Experience dictates that mutations located this close to the end of
a rescuingDNA fragment rescue very poorly if at all (Turner et al.,
2007). Limited additional analysis of thismutant suggests that it is
not completely defective in either J3R or J4R gene activity at thenon-permissive temperature. First, Dts40 complements other
mutants in J4R (Lackner et al., 2003), specifically Cts7 and
Dts44, suggesting that Dts40 can supply J4R gene function (an
RNA polymerase subunit, rpo22) in mixed infections under non-
permissive conditions. J3R encodes a multifunctional protein that
serves as a poly(A) polymerase processivity factor, a (nucleoside-
2′-O-) methyltransferase and a postreplicative transcription elon-
gation factor. Only the elongation activity is essential for virus
replication, and phenotypically, J3R null mutants are dependent
on the elongation enhancing drug, isatin-β-thiosemicarbazone
(IBT) (Latner et al., 2002, 2000). However, we found that Dts40
was sensitive to IBT at both permissive and non-permissive
temperatures (data not shown), suggesting that at least some J3R
gene activity is expressed in Dts40 mutant infections. We
hypothesize based on these observations that Dts40 is partially
defective in both J3R and J4R function under non-permissive
conditions, similar to other doublemutants we have characterized.
As noted above, nine of the unmapped complementation
groups mapped to genes containing previously isolated tempera-
ture-sensitive mutations. Thus in the prior complementation
analysis these mutants complemented mutants in the same gene,
that is, they were false positives. Specifically, five unmapped
complementation groups, each containing a single mutant, each
mapped to a different gene containing a previously mapped
temperature-sensitive mutation (U1 =Cts57 = I8R, U15 =Dts61 =
D11L, U17 = Dts77 = A3L, U18 = Dts78 = H4L, U21 = Dts95 =
D6R). One unmapped group (U5) contained four mutants that
Fig. 3. Gene specific marker rescue mapping of Cts13. A) A map of a portion of the HindIII A fragment of the vaccinia genome. The positions of genes (arrows) and
LM28 are indicated. B) Marker rescue of Cts13. Dishes were infected with Cts13, transfected with pools of PCR fragments as indicated, incubated at 39.7 °C for
4 days, and stained with crystal violet.
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analyses. Lastly, three unmapped groups (U7, U8, U20)
comprising fourmutants mapped to a single gene,E9L, containing
a single mutant from previous analyses. There exist two possible
explanations for the false positive complementation results: 1) The
complementation analysis was done using a qualitative spot test,
which does not formally discriminate between complementation
and recombination, thus it is possible that plaques formed during
the analysis and scored as complementation actually represented
wild type virus formed by intragenic recombination. Our previous
experience, gained entirely with mutants in the WR strain of
vaccinia, shows that intragenic recombination occurs only with a
very low frequency at the non-permissive temperature, and
historically, false positives have not been observed in the com-Fig. 4. DNA sequence of Dts40. The nucleotide sequence encoding the overlap betw
respective translations above the sequence. Wild type sequence is shown at the top and
G to A transition is underlined in each sequence. The single letter amino acid code
peptide. Dots (…) indicate that the protein continues upstream (J3R) or downstreamplementation spot test (Condit and Motyczka, 1981; Condit et al.,
1983). We note that all but one of the false positive results involve
mixed infections between mutants in two different virus strains,
WR (Condit collection) and IHDW (Dales collection), suggesting
that intragenic recombination between these strains may be more
facile compared to intragenic recombination between mutants
within the WR strain. 2) It is possible that the “false positives” in
the complementation analysis actually represent genuine intra-
genic complementation. Intragenic complementation has been
observed previously among mutants in gene A24R, the second
largest subunit of the viral RNA polymerase (Hooda-Dhingra
et al., 1990). Intragenic complementation carries interest-
ing implications regarding the function of a gene, for example
it may indicate that the gene product functions as a multimer.een the carboxy terminus of J3R and the amino terminus of J4R is shown, with
theDts40mutant sequence is shown at the bottom. The mutant nucleotide in the
is positioned above the first nucleotide in the relevant reading frame for each
(J4R).
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here could be accomplished ultimately using a quantitative
complementation analysis, which can discriminate between
complementation and intragenic recombination. Importantly, we
have encountered no incidence of false negative results in the
complementation analysis, that is, all non complementingmutants
that have been mapped have mapped to a unique gene.
DNA sequence analysis
Seventy-two of the 129 mutants have been subjected to DNA
sequence analysis (Supplementary Table 1). Of these, 54 were
reported previously and 18 new sequenceswere determined duringFig. 5. Viral DNA replication in mutant infected cells. Cells were infected with the ind
viral DNA by slot blot hybridization with a radiolabeled vaccinia specific DNA prothe course of this work. Two features of the sequence analysis are
noteworthy: 1) Not all mutants contain simplemissense mutations.
Mutants in two genes contain frameshift (A28R) or nonsense (G3L)
mutations leading to truncated protein products (Turner et al.,
2007), and one mutant (Cts19 in gene E8R) changes the initiating
methionine codon to a leucine codon, effectively creating a null
mutation (Kato et al., 2007). Furthermore, seven mutants contain
two or even three coding changes. 2) Five sibling pairs have been
revealed in five different genes, A28R, A30L, D1R, E8R and I7L.
This raises the possibility that the collection contains additional
sibling pairs. Thus in order to reduce unnecessarily redundant
effort it is advisable to obtain sequence information onmutants in a
given gene prior to pursuing detailed phenotypic analysis.icated viruses at moi=10, incubated at 31 °C (♦) or 39.7 °C (■) and assayed for
be as described in Materials and methods.
Table 3
Summary of mutants by gene
a dbl = double mutant, the smallest fragments producing rescue are indicated.
b Genes mapped by marker rescue are underlined; all others are assigned to the indicated gene by complementation.
c Viral protein synthesis at the non-permissive temperature assayed by metabolic labeling and gel electrophoresis. Normal = indistinguishable from wild type;
Defective early = decreased synthesis of early proteins; Early only = extended early protein synthesis, no late protein synthesis; Defective late = decreased or delayed
late protein synthesis; Abortive late = late shut off of all protein synthesis. (See Condit and Motyczka, 1981; Condit et al., 1983).
d Viral DNA replication at the non-permissive temperature.
e Electron microscope phenotype at the non-permissive temperature. Entries denote the most mature normal structure visualized. Abnormal structures may be present
as well. Negative = no evidence of viral infection; IV = immature virions; IVN = immature virions with nucleoids; MV = mature virions. Some groups display a range
of phenotypes as indicated.
219S.E.M. Kato et al. / Virology 375 (2008) 213–222DNA replication
This study mapped new mutants to three genes previously
shown to be required for DNA replication, A20R (DNA
polymerase processivity factor), B1R (protein kinase), andE9L (DNA polymerase). We therefore assayed these mutants for
DNA replication to provide additional support for the mapping
assignments. The B1R protein kinase mutant Dts15 was
previously reported to be DNA positive, and we confirmed
this result (data not shown). Fig. 5 shows that the A20R mutant
220 S.E.M. Kato et al. / Virology 375 (2008) 213–222Dts48 and the E9L mutants Dts20, Dts83 and Dts97 are DNA
negative as predicted. Interestingly, the E9L mutant Dts18 is
DNA positive, though DNA replication is reduced by approxi-
mately one half at the non-permissive temperature relative to the
permissive temperature. The DNA positive phenotype of Dts15
and Dts18 could suggest that these mutants segregate multiple
functions of the affected genes. For example, Dts15 could be
specifically defective in phosphorylation of targets required for
virus production but not for DNA replication. Likewise, Dts18
could be specifically defective in a DNA polymerase function
such as recombination that is not absolutely required for max-
imal DNA replication. Alternatively, these mutants may simply
be phenotypically leaky. Further experiments are required to
distinguish among these possibilities.
Summary and conclusions
The final combined collection (discounting double mutants)
contains 124 temperature-sensitive mutants affecting 38 viral
genes (Table 3). Importantly, not all mutants assigned to a given
gene have actually been mapped to that gene by marker rescue;
many of the assignments are based solely on complementation
analysis. While this complementation analysis has to date proven
remarkably reliable, nevertheless it would be advisable to
confirm any given assignment by marker rescue before investing
significant effort in characterizing an unmapped allele.
The mutants in the combined collection affect genes in all of
the essential aspects of viral replication, including gene
expression, DNA replication and virion structure and assembly.
Over time the mutants have been of value in dissecting the roles
of individual genes in the virus replication cycle, and we believe
that they will continue to serve this purpose indefinitely.
Materials and methods
Cells and virus culture
BSC40 cells, a continuous line of African green monkey
kidney cells, were grown in Dulbecco'sModified Eagle medium
(DME) supplemented with 10% fetal bovine serum at 37 °Cwith
5% CO2. The temperature-sensitive mutant viruses (ts) used in
this study were isolated and some were characterized previously
(Dales et al., 1978; Condit and Motyczka, 1981; Condit et al.,
1983; Lackner et al., 2003). Wild type virus strains WR and
IHDW and the conditions for virus culture, virus infection and
plaque titration have been described in detail (Dales et al., 1978;
Condit andMotyczka, 1981; Condit et al., 1983). For virological
studies of the mutants, 31 and 39.7 °C were used as permissive
and non-permissive temperatures, respectively.
PCR based marker rescue
One-step marker rescue of mutants was carried out as a
modification of the previously described protocol (Thompson
and Condit, 1986). Briefly, 60-mm dishes of BSC40 cells were
infected with 0.5 ml of each virus at an appropriate moi
determined empirically by terminal dilution. After a 1-houradsorption at 31 °C, the inoculumwas removed and replacedwith
4 ml of Opti-MEM I Reduced Serum Medium (GIBCO)
containing no serum. Infected monolayers were transfected
with 1.5 μg of pcr products corresponding to regions of vaccinia
virus WR genome. Transfection was done with 200 μl of
lipofectamine reagent (Invitrogen Life Technologies)-complexed
DNA which was added drop-wise to the medium. Briefly, the
lipofectamine–DNA complex was prepared by adding the DNA
suspension (1.5 μg of DNA in 100 μl of Opti-MEM) to the
lipofectamine reagent mix (14 μl lipofectamine reagent and 86 μl
Opti-MEM). The infected-transfected cells were incubated
overnight at 39.7 °C and on the following day the medium was
replaced with fresh media (DME) containing serum. The
infected-transfected monolayers were incubated at 39.7 °C for
an additional 3 days. On the fourth day of infection the cells
were stained with crystal violet solution and analyzed for the
presence or absence of wild type plaques. Occasionally we
observed a high background of plaques in several dishes which
could be attributed to contamination of a PCR product with the
genomic wt viral DNA template. This background could
usually be reduced or eliminated by synthesizing second
generation PCR fragments using a small amount of the original
PCR fragment as a template and thus effectively diluting the
genomic wt DNA contamination.
PCR and primers
Mapping of mutant viruses was done by sequential marker
rescues using three series of PCR products spanning all or parts of
the viral genome. The first series of long PCR fragments was
prepared with a set of DNA oligonucleotide primers designed by
Yao and Evans (2003) and together amplified nearly all of
vaccinia virus genome in a series of 13 products ranging between
12 and 22 kb. The second series of PCR fragments used to refine
the mapping was generated with a set of oligonucleotide primers
designed by Luttge and Moyer (2005) which amplifies the entire
genome in a series of 40 5-kb products. PCR reactions were
carried out using the Roche Expand long template PCR kit
(Buffer system 3 for the 11–21 kb series of PCR products and
Buffer system 2 for the 5-kb PCR products) and these PCR
amplified DNAs were purified with Amicon Microcon centrifu-
gal filter devices (Millipore) before use in the marker rescue. The
third series of PCR products was prepared using a set of primers
that amplified specific individual open reading frames in a
reaction containing Deep Vent DNA polymerase (New England
Biolabs) and Taq polymerase. These PCR products were purified
with High Pure PCR Product Purification kit (Roche) used as
directed by the manufacturer.
Preparation of vaccinia virus DNA
Wild type vaccinia virus (WR) genomic DNAwas prepared
essentially as described previously (Condit et al., 1983; Esposito
et al., 1981). Total infected cell DNA to be used for sequencing
was prepared using DNeasy tissue kit (Qiagen) according to the
manufacturer's instructions for isolation of DNA from animal
cells in culture as previously described (Latner et al., 2000).
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DNA sequence of specific genes from wt or mutant viruses
was obtained by direct sequencing of PCR products amplified
from total infected cell DNA or purified viral genomic DNA,
prepared as described above. The entire open reading frame
was PCR amplified using two primers that hybridize outside of
the open reading frame. Sequence was obtained using the
amplification primers and additional primers that hybridize
within the coding sequence. Sequencing was performed by
the University of Florida ICBR DNA Sequencing Core
Laboratory.
Viral DNA replication analysis
Viral DNA replication was analyzed as described previously
(Traktman and Boyle, 2004). Briefly, BSC40 cells were infected
at moi=10 and incubated at 31 °C or 39.7 °C. At various times
post infection cells were harvested by scraping and centrifuga-
tion. The cells were washed once with phosphate buffered saline
(PBS) and resuspended in a solution of 10× SSC (1.5 M NaCl,
150 mM sodium citrate) and 1 M ammonium acetate. Samples
were subjected to three cycles of freeze/thawing to disrupt the
cells and were stored at −20 °C. The samples were applied to a
Nytran Supercharge nylon transfer membrane (Schleicher &
Schuell) on a Minifold II Slot-Blotter apparatus (Schleicher &
Schuell). Before removing the membrane from the slot blot
apparatus, the DNA was denatured with a solution of 0.5 M
NaOH/1.5 M NaCl and then neutralized with two washes of 10×
SSC. The membrane was pre-hybridized at 42 °C in a
hybridization oven (Labnet International, Inc) for at least 2 h
in a buffer containing 6× SSC, 50% formamide, 0.5% SDS, 5×
Denhardts solution (0.1% BSA, 0.1% polyvinylpyrolidone,
0.1% Ficoll), and 100 μg/ml denatured salmon sperm DNA.
After pre-hybridization, 2.25×106 cpm of the randomly labeled
(DECAprime II kit (Ambion)) vaccinia HindIII E fragment
probe was added to fresh hybridization solution and incubated
with the membranes overnight at 42 °C. The membranes were
washed three times with 2× SSC at room temperature followed
by two washes with 0.2× SSC/0.1% SDS at 55 °C. The mem-
branes were exposed to film and were then quantified with a
phosphor screen (Molecular Dynamics) and analyzed by a
Storm phosphorimager (Molecular Dynamics) and the Image-
Quant software program (Molecular Dynamics).
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